SOM230: A new therapeutic modality for Cushing's disease

被引：0
|
作者：
Lewis, Ian [1 ]
Pless, Janos [2 ]
Kneuer, Rainer [1 ]
Silva, Antonio [2 ]
Hoyer, Daniel [2 ]
Weckbecker, Gisbert [2 ]
Bruns, Christian [2 ]
Schmid, Herbert A. [2 ]
机构：
[1] Novartis Inst Biomed Res, Dept Exploratory Med Chem Global Discovery Chem, CH-4002 Basel, Switzerland
[2] Novartis Inst Biomed Res, Dept Autoimmune Oncol & Nervous Syst Res, CH-4002 Basel, Switzerland
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
164-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Profiling SOM230: a novel multi-ligand somatostatin analog
    Tran, LL
    Schmid, HA
    PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 831 - 835
  • [32] Phase II trial of SOM230 in patients with unresectable hepatocellular carcinoma (HCC).
    Feun, Lynn G.
    Savaraj, Niramol
    Wangpaichitr, Medhi
    Richman, Stephen P.
    Kwon, Deukwoo
    Dinh, Vy
    Martin, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [33] Stimulatory effect of SOM230 on human and rat adrenal corticosteroid secretion in vitro
    Giraldi, F. Pecori
    Pagliardini, L.
    Cassarino, M. F.
    Martucci, F.
    Sesta, A.
    Castelli, L.
    Montanari, E.
    Schmid, H. A.
    Cavagnini, F.
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2012, 178 (02) : 436 - 439
  • [34] Pasireotide (SOM230) as a Potential Treatment for Endocrine and Non-Endocrine Tumors
    Schmid, Herbert A.
    CURRENT DRUG THERAPY, 2010, 5 (04) : 301 - 311
  • [35] Regulation of CRH-induced secretion of ACTH and corticosterone by SOM230 in rats
    Silva, AP
    Schoeffter, P
    Weckbecker, G
    Bruns, C
    Schmid, HA
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (03) : R7 - R10
  • [36] Pasireotide (SOM230) protects the retina in animal models of ischemia induced retinopathies
    Kokona, D.
    Mastrodimou, N.
    Pediaditakis, I.
    Charalampopoulos, I.
    Schmid, H. A.
    Thermos, K.
    EXPERIMENTAL EYE RESEARCH, 2012, 103 : 90 - 98
  • [37] Preclinical and clinical experience with SOM230 a novel multi-ligand somatostatin analog
    Tran, Ly-Le
    Schmid, Herbert A.
    ANNALS OF ONCOLOGY, 2004, 15 : 110 - 110
  • [38] Somatostatin analogue pasireotide (SOM230) inhibits catecholamine secretion in human pheochromocytoma cells
    Streit, Laura
    Moog, Sophie
    Hugel, Sylvain
    Rame, Marion
    Tanguy, Emeline
    Andry, Virginie
    Schmid, Herbert A.
    Brunaud, Laurent
    Bihain, Florence
    Nomine-Criqui, Claire
    Goumon, Yannick
    Lacomme, Stephanie
    Lomazzi, Sandra
    Vix, Michel
    Mutter, Didier
    Vitale, Nicolas
    Ory, Stephane
    Gasman, Stephane
    CANCER LETTERS, 2022, 524 : 232 - 244
  • [39] The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas
    Batista, Dalia L.
    Zhang, Xun
    Gejman, Roger
    Ansell, Peter J.
    Zhou, Yunli
    Johnson, Sarah A.
    Swearingen, Brooke
    Hedley-Whyte, E. Tessa
    Stratakis, Constantine A.
    Klibanski, Anne
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11): : 4482 - 4488
  • [40] The Synergistic Effect of Pasireotide (SOM230) and a Raf-1 Activating Agent in Carcinoids
    Somnay, Yash
    Chen, Herbert
    Kunnimalaiyaan, Muthusamy
    PANCREAS, 2012, 41 (02) : 341 - 341
12345